about
The binding sites for the very low density lipoprotein receptor and low-density lipoprotein receptor-related protein are shared within coagulation factor VIIIInteraction of coagulation factor VIII with members of the low-density lipoprotein receptor family follows common mechanism and involves consensus residues within the A2 binding site 484-509Interaction of fibrin(ogen) with fibronectin: further characterization and localization of the fibronectin-binding site.Identification of coagulation factor VIII A2 domain residues forming the binding epitope for low-density lipoprotein receptor-related protein.Level of overall hemostasis potential in donor and patient plasma in pathology.Factor XIIIa incorporates thymosin beta4 preferentially into the fibrin(ogen) alphaC-domains.[The use of monoclonal antibodies for research on fibrin polymerization processes]The study of fibrin polymerization with monoclonal antibodies[Role of the K4 and K5 plasmin heavy chain kringles in the fibrin clot structure destruction][Functional and diagnostic significance of A-, Bbeta 1-42 and Bbeta 15-42 peptide fragments of fibrin(ogen)][Plasminogen activators in malignant tissues and lungs of mice during metastatic spreading and administration of various pharmacological agents][The effect of N,N'-dicyclohexylcarbodiimide on the Ca2+ transport enzyme system of muscle microsome fractions][Mg2+-dependent, Ca2+-activated ATPase of the plasmatic membranes of the synaptosomes][Mg2+-dependent Ca2+-activated ATPase activity in a brain microsomal fraction][The effect of kringles K1-3, K4 and K5 on lysis of fibrin clots caused by the activation of Glu- and Lys-plasminogen by a tissue activator][The effect of heparin on the proteolytic and fibrinolytic activity on plasmin(ogen) and fibrin clot lysis][Fibrin fragment beta 15-118. Inhibitory and complex-forming properties][Study of the polymerization of fibrin using monoclonal antibodies 2D-2A and their Fab-fragments]Thermal stability of individual domains in platelet glycoprotein IIbIIIaActivating effect of the plasminogen activators on plasminogens of different mammalia species[Use of a turbidimetric method to study the kinetics of inhibition of fibrinolysis in diluted blood plasma][Methods of derivation and physico-chemical properties of plasminogen activators][Comparative evaluation of fibrinogen and fibrin hydrolysis with plasmin][Evaluation of equilibrium between coagulating and fibrinolytic blood systems in practically healthy people in various physiologic states using the original express-micromethod]Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sitesInvestigation of the plasminogen-streptokinase interactionFormation and dissolution of fibrin in model systemsComputer modelling of fibrin assemblyStudies of the t-PA-catalyzed Glu-plasminogen activation on different models of polymeric fibrin[Isolation of platelet integrin GPIIbIIIa, preparation of its chymotrypsin fragments and IIIa subunit][Features of the structure of fibrin clots, connected with conditions of gel formation][Heparin effect on hydrolysis of fibrin clots in a bull and a man with varying fibrinolytic systems][Modifying effect of antiplasminogen monoclonal antibody IV-1c on human plasmin catalytic properties][Role of lysine binding sites in activation of plasminogen by streptokinase]Localization of the low-density lipoprotein receptor-related protein regions involved in binding to the A2 domain of coagulation factor VIIIDepletion of CD25+ cells from human T-cell enriched fraction eliminates immunodominance during priming with dendritic cells genetically modified to express a secreted protein[Effect of protein C activator on overall haemostasis potential in donor and hip arthroplasty patient plasma]Fibrin(ogen)olytic and platelet modulating activity of a novel protease from the Echis multisquamatis snake venom
P50
Q28268821-0C92B2BC-976C-456B-AFDE-8FC218C89E52Q28289964-6265951A-4CA8-47FF-8AEE-157077D8C2FBQ34524158-FBC27F09-02D5-423D-8B62-80D55DCB7A8FQ46929370-19506DC0-A7B3-41CD-9313-A3D8D32D8030Q49947397-32181CFB-7F59-480B-8B60-4E628B2F3C1BQ50789120-770186F7-3AA4-4E16-A629-F7ABC5D87058Q67700095-47136C2C-1D51-441E-A611-05834CC23AC9Q67781289-3E54FF70-4B85-4A56-882E-0CFB04A1A54DQ67914416-0165A6AA-AEE0-4974-A14A-0E58ED15F523Q67946980-8DE4E703-3386-4A90-BAFE-C2570A1D3863Q67999877-F71888F6-316F-4BD7-B929-CF7DEE650776Q68528095-31A1447B-8188-4C7C-BB85-094758B1947EQ68528756-4912A5B5-78D5-4053-9D66-844BC57DB23EQ68542286-41DABE70-80D7-4C6A-A3F6-59764339541AQ69253039-A8FDD417-BEBD-445B-A2F4-681338183276Q69316325-33295983-B880-4A78-91DF-FC11ED1C9408Q70878787-E6E17CFC-5515-47C5-9A3A-8F9EB272FE00Q70968829-674DD186-0711-4C50-9EFC-C44F90112A16Q71057348-52B23DD1-C7D0-4622-847B-5733522BABB9Q71543712-0B86C776-63D4-469A-9F20-EA9690987CD0Q71692613-93430D6A-A825-40EC-90CC-B98AF95C1912Q72703656-96E79F0E-15CC-4410-849E-EEC9785AF8CDQ72788939-24E30D11-040B-46C1-B24E-0069DD840685Q72840729-421D452D-281E-4215-9CE7-A1243E36FC88Q73313392-2C903F63-8A8C-48B7-AD64-0950CC2B195FQ73517934-F81AEF2A-E99C-414F-8A7B-84F5E3B981E8Q73517951-5DCFDA6B-0EED-4BDC-81FA-76A35C5D8722Q73517955-8B794F5C-7553-4A13-91D8-1662564C5D2AQ73579089-189A8A33-A59D-435C-A8B1-C7BC22688AA1Q74174433-2CB77F88-F212-4947-9477-61E0091BE94CQ74193692-7977455D-19E5-446D-A153-8B86E537E0D3Q74600493-7F12A97F-6E21-4A35-BE1E-F55BE8489F97Q76328165-AC47F1C1-66D3-4FCD-826A-947146509E74Q79205165-3E30EB0D-5153-4C48-A80F-65D9BBB57A42Q80158297-A9113047-7F61-4C59-83B0-C3A50F2E5CEFQ80580563-145390D5-60B4-4B31-B4E7-1673F052E075Q83322587-8A467AD9-6251-488F-9772-11605B234A0FQ87420552-8574D77C-5F35-4F73-89E5-87B1438F83DE
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
E M Makogonenko
@ast
E M Makogonenko
@en
E M Makogonenko
@es
E M Makogonenko
@nl
type
label
E M Makogonenko
@ast
E M Makogonenko
@en
E M Makogonenko
@es
E M Makogonenko
@nl
prefLabel
E M Makogonenko
@ast
E M Makogonenko
@en
E M Makogonenko
@es
E M Makogonenko
@nl
P31
P496
0000-0003-2597-4373